Cargando…
Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect
Intratumoural administration of unmethylated cytosine-phosphate-guanine motifs (CpG) to stimulate toll-like receptor (TLR)-9 has been shown to induce tumour regression in preclinical studies and some efficacy in the clinic. Because activated natural killer T (NKT) cells can cooperate with pattern-re...
Autores principales: | Prasit, Kef K, Ferrer-Font, Laura, Burn, Olivia K, Anderson, Regan J, Compton, Benjamin J, Schmidt, Alfonso J, Mayer, Johannes U, Chen, Chun-Jen J, Dasyam, Nathaniel, Ritchie, David S, Godfrey, Dale I, Mattarollo, Stephen R, Dunbar, P Rod, Painter, Gavin F, Hermans, Ian F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196710/ https://www.ncbi.nlm.nih.gov/pubmed/35712122 http://dx.doi.org/10.1080/2162402X.2022.2081009 |
Ejemplares similares
-
Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists
por: Burn, Olivia K., et al.
Publicado: (2020) -
Harnessing NKT cells for vaccination
por: Burn, Olivia K, et al.
Publicado: (2021) -
NKT cell adjuvants in therapeutic vaccines against hematological cancers
por: Mattarollo, Stephen R., et al.
Publicado: (2013) -
NKT cell-dependent glycolipid–peptide vaccines with potent anti-tumour activity
por: Anderson, Regan J., et al.
Publicado: (2015) -
New ways to turn on NKT cells
por: Godfrey, Dale Ian, et al.
Publicado: (2011)